- Filed
- Oct 15, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Oct 15, 2024 | 6.7M sh |
| Cash And Equivalents | Q2 2025 · Aug 31, 2024 | $33 |
| Cash And Equivalents | Q2 2025 · Feb 29, 2024 | $9.07K |
| Current Liabilities | Q2 2025 · Aug 31, 2024 | $93.58K |
| Current Liabilities | Q2 2025 · Feb 29, 2024 | $80K |
| Current Assets | Q2 2025 · Aug 31, 2024 | $36.53K |
| Current Assets | Q2 2025 · Feb 29, 2024 | $84.87K |
| Total Assets | Q2 2025 · Aug 31, 2024 | $99.87K |
| Total Assets | Q2 2025 · Feb 29, 2024 | $108.06K |
| Operating Income | Q2 2025 · Aug 31, 2024 | $21.77K |
| Cost Of Revenue | Q2 2025 · Aug 31, 2024 | $10.61K |
| Cost Of Revenue | Q2 2025 · Aug 31, 2024 | $14.58K |
| Cost Of Revenue | Q2 2025 · Aug 31, 2023 | $7K |
| Cost Of Revenue | Q2 2025 · Aug 31, 2023 | $14.93K |
| Revenue | Q2 2025 · Aug 31, 2024 | $10.61K |
| Revenue | Q2 2025 · Aug 31, 2024 | $14.58K |
| Revenue | Q2 2025 · Aug 31, 2023 | $7K |
| Revenue | Q2 2025 · Aug 31, 2023 | $14.93K |
| Shares Diluted | Q2 2025 · Aug 31, 2023 | 5M sh |
| Shares Diluted | Q2 2025 · Aug 31, 2023 | 5M sh |
| Operating Cash Flow restated | Q2 2025 · Aug 31, 2023 | −$329 |
| Stockholders Equity | Q2 2025 · Aug 31, 2023 | −$4.64K |
| Stockholders Equity | Q2 2025 · May 31, 2023 | −$820 |
| Stockholders Equity | Q2 2025 · Feb 28, 2023 | $929 |
| Eps Diluted | Q2 2025 · Aug 31, 2023 | $0.00 |
| Eps Diluted | Q2 2025 · Aug 31, 2023 | $0.00 |
| Sga Expense | Q2 2025 · Aug 31, 2023 | $10.82K |
| Sga Expense | Q2 2025 · Aug 31, 2023 | $20.5K |
| Net Income | Q2 2025 · Aug 31, 2023 | −$3.82K |
| Net Income restated | Q2 2025 · Aug 31, 2023 | −$5.57K |
| Net Income | Q2 2025 · May 31, 2023 | −$1.75K |
| Gross Profit | Q2 2025 · Aug 31, 2023 | $7K |
| Gross Profit | Q2 2025 · Aug 31, 2023 | $14.93K |